🚧 構築中 — データが不正確な場合があります。企業や指標を随時追加しています。
Becton, Dickinson and Company logo

Becton, Dickinson and Company

BDX順位 #263ヘルスケア医療器具・消耗品

時価総額

$49.2B

世界順位

#263

過去最高値

$51.5B

2019-12-31

総成長率

+0%

2026年以降

Market Cap Context

Becton, Dickinson and Company Financial Breakdown (FY 2025)

Source: Yahoo Finance — BDX annual filings (2025)

$21.8B revenue · $3.0B operating income · $1.7B net income

  • Operating margin: 13.7% on $21.8B in revenue.
  • R&D is 5.8% of revenue ($1.3B).
  • Net income margin: 7.7% — $1.7B in profit.
  • Free cash flow: $2.7B (12.2% of revenue).

Cost / Operating Expenses

Total operating expenses $18.9B

Total

$18.5B

Cost of revenue· Product / service delivery costs (COGS)$11.9B64.6%
Research & development$1.3B6.9%
Selling, general & administrative· Sales, marketing, and corporate overhead$5.3B28.6%

Capital Expenditures

$0.8B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$2.7B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

Becton, Dickinson and Companyについて

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.

Becton, Dickinson and Companyの時価総額推移 (20262026)

Becton, Dickinson and Company vs Sector Peers by Market Cap

Takeda Pharmaceutical Company Limited4502.T
$61.0B
Becton, Dickinson and CompanyBDX
$49.2B
CSL LimitedCSL.AX
$49.1B
Humana Inc.HUM
$45.9B
IDEXX Laboratories, Inc.IDXX
$43.6B
Veeva Systems Inc.VEEV
$39.4B
DexCom, Inc.DXCM
$33.8B
Biogen Inc.BIIB
$31.4B

Becton, Dickinson and Companyを比較

順位の推移

時価総額順位前年比
2026$49.2B#263(10)+19.4%
2025$41.3B#273(29)-12.7%
2024$47.2B#244(21)-5.4%
2023$50.0B#223(48)-2.7%
2022$51.3B#175(34)+5.1%
2021$48.9B#209(29)+1.9%
2020$48.0B#180(43)-6.8%
2019$51.5B#137(10)+22.2%
2018$42.1B#127(16)+6.6%
2017$39.5B#143(8)+31.4%
2016$30.1B#151(5)+9.2%
2015$27.5B#146(13)+12.6%
2014$24.4B#159(14)+28.4%
2013$19.0B#173(8)+44.5%
2012$13.2B#181(15)+7.2%
2011$12.3B#166(12)-9.8%
2010$13.6B#154(1)+9.4%
2009$12.5B#153(26)+17.7%
2008$10.6B#127(30)-17.1%
2007$12.8B#157(6)+20.7%
2006$10.6B#163(4)+18.4%
2005$8.9B#159(12)+7.1%
2004$8.3B#147(13)+39.9%
2003$6.0B#160(4)+35.6%
2002$4.4B#156(8)-6.3%
2001$4.7B#164(15)-3.2%
2000$4.9B#149(19)+30.2%
1999$3.7B#130(42)-36.3%
1998$5.8B#88(25)+72.3%
1997$3.4B#113(9)+16.7%
1996$2.9B#104(10)+17.0%
1995$2.5B#94(4)+58.6%
1994$1.6B#90

その他のヘルスケア企業

よくある質問

What is Becton, Dickinson and Company's market cap?

Becton, Dickinson and Company (BDX) has a market capitalization of $49.2B, making it the #263 largest company in the world by market cap.

What was Becton, Dickinson and Company's highest market cap?

Becton, Dickinson and Company's all-time high market cap was $51.5B, reached in 2019-12-31. Its highest rank was #137 in 2019.

What sector is Becton, Dickinson and Company in?

Becton, Dickinson and Company is in the Healthcare sector, specifically the Medical Instruments & Supplies industry. It is based in United States.

How has Becton, Dickinson and Company's market cap changed over time?

Becton, Dickinson and Company has been tracked since 2026. Its market cap has grown by 0% from $49.2B in 2026 to $49.2B today.